Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed

Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme
Chantal M C BassettGrant N Pierce

Abstract

Functional foods and nutraceuticals are becoming popular alternatives to pharmacological treatments by providing health benefits and (or) reducing the risk of chronic diseases. Flaxseed is a rich source of 3 components with demonstrated cardioprotective effects: the omega-3 fatty acid alpha-linolenic acid (ALA), dietary fibre, and phytoestrogen lignans. Multiple clinical dietary intervention trials report that consuming flaxseed daily can modestly reduce circulating total cholesterol (TC) by 6%-11% and low-density lipoprotein (LDL) cholesterol by 9%-18% in normolipemic humans and by 5%-17% for TC and 4%-10% for LDL cholesterol in hypercholesterolemic patients, as well as lower various markers associated with atherosclerotic cardiovascular disease in humans. Evidence to date suggests that the dietary fibre and (or) lignan content of flaxseed provides the hypocholesterolemic action. The omega-3 ALA found in the flaxseed oil fraction also contributes to the antiatherogenic effects of flaxseed via anti-inflammatory and antiproliferative mechanisms. Dietary flaxseed may also protect against ischemic heart disease by improving vascular relaxation responses and by inhibiting the incidence of ventricular fibrillation.

Associated Clinical Trials

Mar 29, 2013·Dr. Heather Blewett

References

Aug 1, 1995·Kidney International·W F ClarkB J Holub
Jan 1, 1995·The American Journal of Clinical Nutrition·S C CunnaneD J Jenkins
Mar 1, 1993·The British Journal of Nutrition·S C CunnaneD J Jenkins
Mar 15, 2002·The Lancet Infectious Diseases·Maija Leinonen, Pekka Saikku
Jun 21, 2003·The American Journal of Clinical Nutrition·Arja T ErkkiläMatti I J Uusitupa
Sep 25, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Paul Lee, Kailash Prasad
Nov 14, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Takashi SanoJunichiro Yamamoto
Dec 21, 2005·The Journal of Nutrition·Charles R HarperTerry A Jacobson
Jul 18, 2006·The American Journal of Clinical Nutrition·Jan L Breslow
Jul 18, 2006·The American Journal of Clinical Nutrition·Sarah K GebauerPenny M Kris-Etherton
Jul 18, 2006·American Journal of Physiology. Heart and Circulatory Physiology·C M C DupasquierG N Pierce
Dec 30, 2006·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Feb 3, 2007·European Journal of Clinical Nutrition·G K PaschosA Zampelas
Mar 9, 2007·The American Journal of Clinical Nutrition·Eddie VosStephen C Cunnane
Jul 10, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Chantal M C DupasquierGrant N Pierce
Mar 11, 2008·Journal of Women's Health·Anagha PatadeBahram H Arjmandi
May 8, 2008·Journal of the American College of Nutrition·LeAnne T BloedonPhilippe O Szapary
May 27, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·J HallundJ M Bruun
Aug 12, 2008·Journal of the American College of Nutrition·J Alejandro AustriaGrant N Pierce
Dec 17, 2008·Journal of Health, Population, and Nutrition·Valerie L FlaxPer Ashorn
Mar 18, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·David J A JenkinsFarley M Mowat

❮ Previous
Next ❯

Citations

Mar 10, 2012·BMC Complementary and Alternative Medicine·Jiqu XuFenghong Huang
Jan 1, 2010·Journal of Biomedicine & Biotechnology·Ben RempelRamaswami Sammynaiken
Oct 25, 2014·Current Hypertension Reports·Stephanie P B CaligiuriGrant N Pierce
Apr 22, 2014·Experimental Gerontology·Stephanie P B CaligiuriGrant N Pierce
Jun 29, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Julie K MasonLilian U Thompson
Apr 11, 2014·BioMed Research International·Mahdi EbrahimiAbdoreza Soleimani Farjam
May 20, 2015·Molecular Nutrition & Food Research·Ilias LagkouvardosThomas Clavel
Jun 15, 2015·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Sorin UrsoniuUNKNOWN Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group
Aug 5, 2016·Antioxidants·Fatma BouazizSemia Ellouz Chaabouni
Aug 2, 2012·Acta Cirúrgica Brasileira·Lívia Hipólito Cardozo BrantGilson Teles Boaventura
Mar 12, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Queila LenziGilson Teles Boaventura
Dec 1, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Juliana Azevedo de MenesesGilson Teles Boaventura
Apr 26, 2014·American Journal of Physiology. Gastrointestinal and Liver Physiology·Leila ZarepoorKrista A Power
Jun 22, 2017·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·M Mohammadi-SartangJ O Totosy de Zepetnek
Nov 5, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Mihir ParikhGrant N Pierce
Jul 30, 2020·The Journal of Nutrition·Ghassan Bkaily, Danielle Jacques

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.